NEW GSK shingles vaccine much more effective

Glaxo Smith Kline received FDA approval for Shingrix a shingles vaccine which is much more effective for people over 60 and especially over 70.

The original vaccine was 70% effective for people in their 50's, 64% for those in their 60's, but only 41% effective for those in their 70's and almost useless for those over 80.

The new vaccine is 97% effective for 50-69 year olds and 91% effective for those over 70.

The new vaccine is better at preventing nerve pain after the shingles rash clears, nearly 90% effective.